{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:13:27Z","timestamp":1777860807407,"version":"3.51.4"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515013048, 2023B0303040004 and 2017B030301018"],"award-info":[{"award-number":["2024A1515013048, 2023B0303040004 and 2017B030301018"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Shenzhen Science and Technology Innovation Commission","doi-asserted-by":"publisher","award":["JCYJ20241202125326035 and JCYJ20200109141212325"],"award-info":[{"award-number":["JCYJ20241202125326035 and JCYJ20200109141212325"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Shenzhen Science and Technology Innovation Commission","doi-asserted-by":"publisher","award":["ZDSYS20230626090803 004"],"award-info":[{"award-number":["ZDSYS20230626090803 004"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32501326"],"award-info":[{"award-number":["32501326"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-70452-w","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T14:22:28Z","timestamp":1773411748000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting Prolyl 3-hydroxylase 1 inhibits pancreatic cancer progression and macrophage immunity"],"prefix":"10.1038","volume":"17","author":[{"given":"Panzhu","family":"Bai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengmin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changying","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6327-4023","authenticated-orcid":false,"given":"Renwei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanyan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiling","family":"Quan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhao","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanfen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siqi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binbin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guizhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wudi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sicong","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2536-4014","authenticated-orcid":false,"given":"Chuanyue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9521-5124","authenticated-orcid":false,"given":"Ruijun","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6706-5720","authenticated-orcid":false,"given":"Ying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"key":"70452_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"70452_CR2","doi-asserted-by":"publisher","first-page":"e214708","DOI":"10.1001\/jamanetworkopen.2021.4708","volume":"4","author":"L Rahib","year":"2021","unstructured":"Rahib, L., Wehner, M. R., Matrisian, L. M. & Nead, K. T. Estimated projection of US cancer incidence and death to 2040. JAMA Netw. Open 4, e214708\u2013e214708 (2021).","journal-title":"JAMA Netw. Open"},{"key":"70452_CR3","doi-asserted-by":"crossref","unstructured":"Siegel, R. L., Miller, K. D., Fuchs, H. E. & Jemal, A. Cancer statistics CA Cancer J. Clin. 72, 7\u201333 (2022).","DOI":"10.3322\/caac.21708"},{"key":"70452_CR4","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","volume":"395","author":"JD Mizrahi","year":"2020","unstructured":"Mizrahi, J. D., Surana, R., Valle, J. W. & Shroff, R. T. Pancreatic cancer. Lancet 395, 2008\u20132020 (2020).","journal-title":"Lancet"},{"key":"70452_CR5","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","volume":"186","author":"CJ Halbrook","year":"2023","unstructured":"Halbrook, C. J., Lyssiotis, C. A., di Magliano, M. P. & Maitra, A. Pancreatic cancer: advances and challenges. Cell 186, 1729\u20131754 (2023).","journal-title":"Cell"},{"key":"70452_CR6","first-page":"1","volume":"2","author":"J Kleeff","year":"2016","unstructured":"Kleeff, J. et al. Pancreatic cancer. Nat. Rev. Dis. Prim. 2, 1\u201322 (2016).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"70452_CR7","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41392-021-00659-4","volume":"6","author":"S Wang","year":"2021","unstructured":"Wang, S. et al. The molecular biology of pancreatic adenocarcinoma: Translational challenges and clinical perspectives. Signal Transduct. Target. Ther. 6, 249 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"70452_CR8","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","volume":"369","author":"DD Von Hoff","year":"2013","unstructured":"Von Hoff, D. D. et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N. Engl. J. Med. 369, 1691\u20131703 (2013).","journal-title":"N. Engl. J. Med."},{"key":"70452_CR9","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41573-021-00345-8","volume":"21","author":"AJ Korman","year":"2022","unstructured":"Korman, A. J., Garrett-Thomson, S. C. & Lonberg, N. The foundations of immune checkpoint blockade and the ipilimumab approval decennial. Nat. Rev. Drug Discov. 21, 509\u2013528 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"70452_CR10","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41571-020-0363-5","volume":"17","author":"WJ Ho","year":"2020","unstructured":"Ho, W. J., Jaffee, E. M. & Zheng, L. The tumour microenvironment in pancreatic cancer\u2014clinical challenges and opportunities. Nat. Rev. Clin. Oncol. 17, 527\u2013540 (2020).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"70452_CR11","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1136\/gutjnl-2015-309193","volume":"65","author":"G Di Caro","year":"2016","unstructured":"Di Caro, G. et al. Dual prognostic significance of tumour-associated macrophages in human pancreatic adenocarcinoma treated or untreated with chemotherapy. Gut. 65, 1710\u20131720 (2016).","journal-title":"Gut"},{"key":"70452_CR12","doi-asserted-by":"publisher","first-page":"5469","DOI":"10.1038\/s41388-019-0803-9","volume":"38","author":"G D\u2019Errico","year":"2019","unstructured":"D\u2019Errico, G. et al. Tumor-associated macrophage-secreted 14-3-3\u03b6 signals via AXL to promote pancreatic cancer chemoresistance. Oncogene 38, 5469\u20135485 (2019).","journal-title":"Oncogene"},{"key":"70452_CR13","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1158\/0008-5472.CAN-12-4115","volume":"73","author":"Y Mao","year":"2013","unstructured":"Mao, Y. et al. Melanoma-educated CD14+ cells acquire a myeloid-derived suppressor cell phenotype through COX-2\u2013dependent mechanisms. Cancer Res. 73, 3877\u20133887 (2013).","journal-title":"Cancer Res."},{"key":"70452_CR14","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.immuni.2017.08.018","volume":"47","author":"Y Zhu","year":"2017","unstructured":"Zhu, Y. et al. Tissue-resident macrophages in pancreatic ductal adenocarcinoma originate from embryonic hematopoiesis and promote tumor progression. Immunity 47, 597 (2017).","journal-title":"Immunity"},{"key":"70452_CR15","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1158\/2159-8290.CD-15-1346","volume":"6","author":"MM Kaneda","year":"2016","unstructured":"Kaneda, M. M. et al. Macrophage PI3Kgamma Drives Pancreatic Ductal Adenocarcinoma Progression. Cancer Discov. 6, 870\u2013885 (2016).","journal-title":"Cancer Discov."},{"key":"70452_CR16","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/s41392-021-00825-8","volume":"6","author":"W Li","year":"2021","unstructured":"Li, W., Li, F., Zhang, X., Lin, H.-K. & Xu, C. Insights into the post-translational modification and its emerging role in shaping the tumor microenvironment. Signal Transduct. Target. Ther. 6, 422 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"70452_CR17","doi-asserted-by":"publisher","first-page":"23615","DOI":"10.1074\/jbc.M312807200","volume":"279","author":"JA Vranka","year":"2004","unstructured":"Vranka, J. A., Sakai, L. Y., & Bachinger, H. P. Prolyl 3-hydroxylase 1, enzyme characterization and identification of a novel family of enzymes. J. Biol. Chem. 279, 23615\u201323621 (2004).","journal-title":"J. Biol. Chem."},{"key":"70452_CR18","doi-asserted-by":"publisher","first-page":"25004","DOI":"10.1074\/jbc.274.35.25004","volume":"274","author":"DJ Wassenhove-McCarthy","year":"1999","unstructured":"Wassenhove-McCarthy, D. J. & McCarthy, K. J. Molecular characterization of a novel basement membrane-associated proteoglycan, leprecan. J. Biol. Chem. 274, 25004\u201325017 (1999).","journal-title":"J. Biol. Chem."},{"key":"70452_CR19","doi-asserted-by":"publisher","first-page":"3576","DOI":"10.1038\/sj.onc.1203696","volume":"19","author":"SC Kaul","year":"2000","unstructured":"Kaul, S. C., Sugihara, T., Yoshida, A., Nomura, H. & Wadhwa, R. Gros1, a potential growth suppressor on chromosome 1: its identity to basement membrane-associated proteoglycan, leprecan. Oncogene 19, 3576\u20133583 (2000).","journal-title":"Oncogene"},{"key":"70452_CR20","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.matbio.2020.03.004","volume":"90","author":"F Tonelli","year":"2020","unstructured":"Tonelli, F. et al. Crtap and p3h1 knock out zebrafish support defective collagen chaperoning as the cause of their osteogenesis imperfecta phenotype. Matrix Biol. 90, 40\u201360 (2020).","journal-title":"Matrix Biol."},{"key":"70452_CR21","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.matbio.2020.02.003","volume":"90","author":"WA Cabral","year":"2020","unstructured":"Cabral, W. A. et al. Substitution of murine type I collagen A1 3-hydroxylation site alters matrix structure but does not recapitulate osteogenesis imperfecta bone dysplasia. Matrix Biol. J. Int. Soc. Matrix Biol. 90, 20\u201339 (2020).","journal-title":"Matrix Biol. J. Int. Soc. Matrix Biol."},{"key":"70452_CR22","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/ng1968","volume":"39","author":"WA Cabral","year":"2007","unstructured":"Cabral, W. A. et al. Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal\/severe osteogenesis imperfecta. Nat. Genet. 39, 359\u2013365 (2007).","journal-title":"Nat. Genet."},{"key":"70452_CR23","doi-asserted-by":"publisher","first-page":"17253","DOI":"10.1074\/jbc.M110.102228","volume":"285","author":"JA Vranka","year":"2010","unstructured":"Vranka, J. A. et al. Prolyl 3-hydroxylase 1 null mice display abnormalities in fibrillar collagen-rich tissues such as tendons, skin, and bones. J. Biol. Chem. 285, 17253\u201317262 (2010).","journal-title":"J. Biol. Chem."},{"key":"70452_CR24","doi-asserted-by":"publisher","first-page":"1374696","DOI":"10.3389\/fonc.2024.1374696","volume":"14","author":"Z Wang","year":"2024","unstructured":"Wang, Z. & Wang, H. The role of P3H family in cancer: implications for prognosis, tumor microenvironment and drug sensitivity. Front. Oncol. 14, 1374696 (2024).","journal-title":"Front. Oncol."},{"key":"70452_CR25","doi-asserted-by":"crossref","unstructured":"Li, Y., Wang, T., Jiang F. Pan-cancer analysis of P3H1 and experimental validation in renal clear cell carcinoma. Appl. Biochem. Biotechnol. 196, 5974\u20135993 (2024).","DOI":"10.1007\/s12010-023-04845-8"},{"key":"70452_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-024-00748-x","volume":"8","author":"G Ding","year":"2024","unstructured":"Ding, G. et al. Multi-omics analysis of Prolyl 3-hydroxylase 1 as a prognostic biomarker for immune infiltration in ccRCC. NPJ Precis. Oncol. 8, 256 (2024).","journal-title":"NPJ Precis. Oncol."},{"key":"70452_CR27","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s10020-023-00648-z","volume":"29","author":"J Jiao","year":"2023","unstructured":"Jiao, J. et al. Paired protein kinases PRKCI-RIPK2 promote pancreatic cancer growth and metastasis via enhancing NF-\u03baB\/JNK\/ERK phosphorylation. Mol. Med. 29, 47 (2023).","journal-title":"Mol. Med."},{"key":"70452_CR28","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1158\/0008-5472.CAN-06-2969","volume":"67","author":"GM Hayes","year":"2007","unstructured":"Hayes, G. M., Carrigan, P. E. & Miller, L. J. Serine-arginine protein kinase 1 overexpression is associated with tumorigenic imbalance in mitogen-activated protein kinase pathways in breast, colonic, and pancreatic carcinomas. Cancer Res. 67, 2072\u20132080 (2007).","journal-title":"Cancer Res."},{"key":"70452_CR29","first-page":"1","volume":"10","author":"C Zhou","year":"2025","unstructured":"Zhou, C. et al. Serine\/threonine\/tyrosine kinase 1 drives pancreatic carcinogenesis via GSK3\u03b2 sequestration-mediated Wnt\/\u03b2-catenin pathway hyperactivation. Signal Transduct. Target. Ther. 10, 1\u201318 (2025).","journal-title":"Signal Transduct. Target. Ther."},{"key":"70452_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02283-9","volume":"9","author":"H Gibori","year":"2018","unstructured":"Gibori, H. et al. Amphiphilic nanocarrier-induced modulation of PLK1 and miR-34a leads to improved therapeutic response in pancreatic cancer. Nat. Commun. 9, 16 (2018).","journal-title":"Nat. Commun."},{"key":"70452_CR31","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1159\/000085280","volume":"5","author":"W Weichert","year":"2005","unstructured":"Weichert, W. et al. Overexpression of Polo-like kinase 1 is a common and early event in pancreatic cancer. Pancreatology 5, 259\u2013265 (2005).","journal-title":"Pancreatology"},{"key":"70452_CR32","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1158\/1535-7163.641.3.5","volume":"3","author":"JrPJ Gray","year":"2004","unstructured":"Gray, J.rP. J. et al. Identification of human polo-like kinase 1 as a potential therapeutic target in pancreatic cancer. Mol. Cancer Ther. 3, 641\u2013646 (2004).","journal-title":"Mol. Cancer Ther."},{"key":"70452_CR33","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.10734","volume":"5","author":"J Wu","year":"2016","unstructured":"Wu, J., Ivanov, A. I., Fisher, P. B. & Fu, Z. Polo-like kinase 1 induces epithelial-to-mesenchymal transition and promotes epithelial cell motility by activating CRAF\/ERK signaling. Elife 5, e10734 (2016).","journal-title":"Elife"},{"key":"70452_CR34","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aau7566","volume":"5","author":"W Li","year":"2019","unstructured":"Li, W. et al. A methylation-phosphorylation switch determines Plk1 kinase activity and function in DNA damage repair. Sci. Adv. 5, eaau7566 (2019).","journal-title":"Sci. Adv."},{"key":"70452_CR35","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s13238-010-0131-x","volume":"1","author":"XS Liu","year":"2010","unstructured":"Liu, X. S., Song, B. & Liu, X. Q. The substrates of Plk1, beyond the functions in mitosis. Protein Cell 1, 999\u20131010 (2010).","journal-title":"Protein Cell"},{"key":"70452_CR36","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.ccr.2009.01.018","volume":"15","author":"L Wang","year":"2009","unstructured":"Wang, L. et al. Oncogenic function of ATDC in pancreatic cancer through Wnt pathway activation and \u03b2-catenin stabilization. Cancer Cell 15, 207\u2013219 (2009).","journal-title":"Cancer Cell"},{"key":"70452_CR37","doi-asserted-by":"publisher","first-page":"e1155","DOI":"10.1371\/journal.pone.0001155","volume":"2","author":"M Pasca di Magliano","year":"2007","unstructured":"Pasca di Magliano, M. et al. Common activation of canonical Wnt signaling in pancreatic adenocarcinoma. PloS ONE 2, e1155 (2007).","journal-title":"PloS ONE"},{"key":"70452_CR38","doi-asserted-by":"publisher","first-page":"4909","DOI":"10.1158\/0008-5472.CAN-12-4384","volume":"73","author":"Y Zhang","year":"2013","unstructured":"Zhang, Y. et al. Canonical wnt signaling is required for pancreatic carcinogenesis. Cancer Res. 73, 4909\u20134922 (2013).","journal-title":"Cancer Res."},{"key":"70452_CR39","doi-asserted-by":"publisher","first-page":"17901","DOI":"10.1074\/jbc.M111635200","volume":"277","author":"M van Noort","year":"2002","unstructured":"van Noort, M., Meeldijk, J., van der Zee, R., Destree, O. & Clevers, H. Wnt signaling controls the phosphorylation status of \u03b2-catenin. J. Biol. Chem. 277, 17901\u201317905 (2002).","journal-title":"J. Biol. Chem."},{"key":"70452_CR40","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S0092-8674(02)00685-2","volume":"108","author":"C Liu","year":"2002","unstructured":"Liu, C. et al. Control of \u03b2-catenin phosphorylation\/degradation by a dual-kinase mechanism. Cell 108, 837\u2013847 (2002).","journal-title":"Cell"},{"key":"70452_CR41","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.cell.2008.01.052","volume":"133","author":"X Wu","year":"2008","unstructured":"Wu, X. et al. Rac1 activation controls nuclear localization of \u03b2-catenin during canonical Wnt signaling. Cell 133, 340\u2013353 (2008).","journal-title":"Cell"},{"key":"70452_CR42","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/382638a0","volume":"382","author":"J Behrens","year":"1996","unstructured":"Behrens, J. et al. Functional interaction of \u03b2-catenin with the transcription factor LEF-1. Nature 382, 638\u2013642 (1996).","journal-title":"Nature"},{"key":"70452_CR43","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1126\/science.275.5307.1784","volume":"275","author":"V Korinek","year":"1997","unstructured":"Korinek, V. et al. Constitutive transcriptional activation by a \u03b2-catenin-Tcf complex in APC\u2212\/\u2212 colon carcinoma. Science 275, 1784\u20131787 (1997).","journal-title":"Science"},{"key":"70452_CR44","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0092-8674(02)01014-0","volume":"111","author":"M Van de Wetering","year":"2002","unstructured":"Van de Wetering, M. et al. The \u03b2-catenin\/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111, 241\u2013250 (2002).","journal-title":"Cell"},{"key":"70452_CR45","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1172\/JCI43937","volume":"122","author":"M Anson","year":"2012","unstructured":"Anson, M. et al. Oncogenic \u03b2-catenin triggers an inflammatory response that determines the aggressiveness of hepatocellular carcinoma in mice. J. Clin. Investig. 122, 586\u2013599 (2012).","journal-title":"J. Clin. Investig."},{"key":"70452_CR46","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.tips.2018.03.008","volume":"39","author":"B Wang","year":"2018","unstructured":"Wang, B., Tian, T., Kalland, K.-H., Ke, X. & Qu, Y. Targeting Wnt\/\u03b2-catenin signaling for cancer immunotherapy. Trends Pharmacol. Sci. 39, 648\u2013658 (2018).","journal-title":"Trends Pharmacol. Sci."},{"key":"70452_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2020.09.026","volume":"496","author":"Y Zhao","year":"2021","unstructured":"Zhao, Y. et al. The VE-Cadherin\/\u03b2-catenin signalling axis regulates immune cell infiltration into tumours. Cancer Lett. 496, 1\u201315 (2021).","journal-title":"Cancer Lett."},{"key":"70452_CR48","doi-asserted-by":"publisher","first-page":"4242","DOI":"10.3390\/ijms20174242","volume":"20","author":"M Ram Makena","year":"2019","unstructured":"Ram Makena, M. et al. Wnt\/\u03b2-catenin signaling: the culprit in pancreatic carcinogenesis and therapeutic resistance. Int. J. Mol. Sci. 20, 4242 (2019.","journal-title":"Int. J. Mol. Sci."},{"key":"70452_CR49","doi-asserted-by":"crossref","unstructured":"Huang, P. et al. Clinical functional proteomics of intercellular signalling in pancreatic cancer. Nature637, 726\u2013735 (2024).","DOI":"10.1038\/s41586-024-08225-y"},{"key":"70452_CR50","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.cels.2023.07.007","volume":"14","author":"YX Liao","year":"2023","unstructured":"Liao, Y. X. et al. A proteogenomics data-driven knowledge base of human cancer. Cell Syst. 14, 777\u2013787 (2023).","journal-title":"Cell Syst."},{"key":"70452_CR51","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1111\/cts.13563","volume":"16","author":"M Posta","year":"2023","unstructured":"Posta, M. & Gyorffy, B. Analysis of a large cohort of pancreatic cancer transcriptomic profiles to reveal the strongest prognostic factors. Clin. Transl. Sci. 16, 1479\u20131491 (2023).","journal-title":"Clin. Transl. Sci."},{"key":"70452_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18244-8","volume":"11","author":"S-W Lu","year":"2020","unstructured":"Lu, S.-W. et al. IL-20 antagonist suppresses PD-L1 expression and prolongs survival in pancreatic cancer models. Nat. Commun. 11, 4611 (2020).","journal-title":"Nat. Commun."},{"key":"70452_CR53","doi-asserted-by":"publisher","first-page":"4333","DOI":"10.7150\/thno.85421","volume":"13","author":"CM Liu","year":"2023","unstructured":"Liu, C. M. et al. Kindlin-2 enhances c-Myc translation through association with DDX3X to promote pancreatic ductal adenocarcinoma progression. Theranostics 13, 4333\u20134355 (2023).","journal-title":"Theranostics"},{"key":"70452_CR54","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1053\/j.gastro.2020.11.044","volume":"160","author":"I Peran","year":"2020","unstructured":"Peran, I. et al. Cadherin 11 promotes immunosuppression and extracellular matrix deposition to support growth of pancreatic tumors and resistance to gemcitabine in mice. Gastroenterology 160, 1359\u20131372 (2020).","journal-title":"Gastroenterology"},{"key":"70452_CR55","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ccell.2017.11.007","volume":"33","author":"BW Renz","year":"2017","unstructured":"Renz, B. W. et al. \u03b22 Adrenergic-neurotrophin feedforward loop promotes pancreatic cancer. Cancer Cell 33, 75\u201390 (2017).","journal-title":"Cancer Cell"},{"key":"70452_CR56","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1053\/j.gastro.2025.01.244","volume":"168","author":"D Yang","year":"2025","unstructured":"Yang, D. et al. TREM2 Depletion in pancreatic cancer elicits pathogenic inflammation and accelerates tumor progression via enriching IL-1\u03b2+ macrophages. Gastroenterology 168, 1153\u20131169 (2025).","journal-title":"Gastroenterology"},{"key":"70452_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-019-1023-1","volume":"18","author":"C-C Weng","year":"2019","unstructured":"Weng, C.-C. et al. Loss of the transcriptional repressor TGIF1 results in enhanced Kras-driven development of pancreatic cancer. Mol. Cancer 18, 1\u201318 (2019).","journal-title":"Mol. Cancer"},{"key":"70452_CR58","doi-asserted-by":"publisher","unstructured":"Tie, Y., Tang, F., Wei, Y. Q. & Wei, X. W. Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets. J. Hematol. Oncol. 15, https:\/\/doi.org\/10.1186\/s13045-022-01282-8 (2022).","DOI":"10.1186\/s13045-022-01282-8"},{"key":"70452_CR59","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li, T. et al. TIMER2. 0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 48, W509\u2013W514 (2020).","journal-title":"Nucleic Acids Res."},{"key":"70452_CR60","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.canlet.2020.10.029","volume":"498","author":"J Yang","year":"2021","unstructured":"Yang, J., Li, Y., Sun, Z. & Zhan, H. Macrophages in pancreatic cancer: An immunometabolic perspective. Cancer Lett. 498, 188\u2013200 (2021).","journal-title":"Cancer Lett."},{"key":"70452_CR61","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3390\/cancers14010194","volume":"14","author":"HG Pratt","year":"2022","unstructured":"Pratt, H. G. et al. Macrophage and neutrophil interactions in the pancreatic tumor microenvironment drive the pathogenesis of pancreatic cancer. Cancers 14, 194 (2022).","journal-title":"Cancers"},{"key":"70452_CR62","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.3390\/cancers13133253","volume":"13","author":"I Larionova","year":"2021","unstructured":"Larionova, I., Kazakova, E., Gerashchenko, T. & Kzhyshkowska, J. New angiogenic regulators produced by TAMs: perspective for targeting tumor angiogenesis. Cancers 13, 3253 (2021).","journal-title":"Cancers"},{"key":"70452_CR63","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41392-025-02325-5","volume":"10","author":"J Xu","year":"2025","unstructured":"Xu, J. et al. Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments. Signal Transduct. Target. Ther. 10, 268 (2025).","journal-title":"Signal Transduct. Target. Ther."},{"key":"70452_CR64","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0065-230X(10)06003-3","volume":"106","author":"EC Keeley","year":"2010","unstructured":"Keeley, E. C., Mehrad, B. & Strieter, R. M. CXC chemokines in cancer angiogenesis and metastases. Adv. Cancer Res. 106, 91\u2013111 (2010).","journal-title":"Adv. Cancer Res."},{"key":"70452_CR65","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/hep.28382","volume":"63","author":"L Locatelli","year":"2016","unstructured":"Locatelli, L. et al. Macrophage recruitment by fibrocystin-defective biliary epithelial cells promotes portal fibrosis in congenital hepatic fibrosis. Hepatology 63, 965\u2013982 (2016).","journal-title":"Hepatology"},{"key":"70452_CR66","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.molmed.2010.01.003","volume":"16","author":"G Lazennec","year":"2010","unstructured":"Lazennec, G. & Richmond, A. Chemokines and chemokine receptors: new insights into cancer-related inflammation. Trends Mol. Med. 16, 133\u2013144 (2010).","journal-title":"Trends Mol. Med."},{"key":"70452_CR67","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1136\/gutjnl-2014-307671","volume":"64","author":"W Yan","year":"2015","unstructured":"Yan, W. et al. Tim-3 fosters HCC development by enhancing TGF-\u03b2-mediated alternative activation of macrophages. Gut 64, 1593\u20131604 (2015).","journal-title":"Gut"},{"key":"70452_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-022-02717-5","volume":"22","author":"P Su","year":"2022","unstructured":"Su, P. et al. Crosstalk between tumor-associated macrophages and tumor cells promotes chemoresistance via CXCL5\/PI3K\/AKT\/mTOR pathway in gastric cancer. Cancer Cell Int. 22, 290 (2022).","journal-title":"Cancer Cell Int."},{"key":"70452_CR69","doi-asserted-by":"publisher","first-page":"3779","DOI":"10.1158\/1078-0432.CCR-22-3273","volume":"29","author":"W Yuan","year":"2023","unstructured":"Yuan, W. et al. Dual role of CXCL8 in maintaining the mesenchymal state of glioblastoma stem cells and M2-like tumor-associated macrophages. Clin. Cancer Res. 29, 3779\u20133792 (2023).","journal-title":"Clin. Cancer Res."},{"key":"70452_CR70","doi-asserted-by":"publisher","first-page":"4378","DOI":"10.62347\/UAIS7070","volume":"14","author":"Y Ou","year":"2024","unstructured":"Ou, Y. et al. The Zeb1-Cxcl1 axis impairs the antitumor immune response by inducing M2 macrophage polarization in breast cancer. Am. J. Cancer Res. 14, 4378 (2024).","journal-title":"Am. J. Cancer Res."},{"key":"70452_CR71","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/nrd3184","volume":"9","author":"K Strebhardt","year":"2010","unstructured":"Strebhardt, K. Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy. Nat. Rev. Drug Discov. 9, 643\u2013660 (2010).","journal-title":"Nat. Rev. Drug Discov."},{"key":"70452_CR72","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1073\/pnas.91.5.1736","volume":"91","author":"U Holtrich","year":"1994","unstructured":"Holtrich, U. et al. Induction and down-regulation of PLK, a human serine\/threonine kinase expressed in proliferating cells and tumors. Proc. Natl. Acad. Sci. USA 91, 1736\u20131740 (1994).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"70452_CR73","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/pro.3978","volume":"30","author":"R Oughtred","year":"2021","unstructured":"Oughtred, R. et al. The BioGRID database: A comprehensive biomedical resource of curated protein, genetic, and chemical interactions. Protein Sci. 30, 187\u2013200 (2021).","journal-title":"Protein Sci."},{"key":"70452_CR74","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1515\/oncologie-2023-0242","volume":"26","author":"X Liu","year":"2024","unstructured":"Liu, X., Chen, X. M., Liu, L., Xia, J. & Zhang, H. AKAP12 inhibits the proliferation of ovarian cancer by activating the Hippo pathway. Oncologie 26, 105\u2013116 (2024).","journal-title":"Oncologie"},{"key":"70452_CR75","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/onc.2016.304","volume":"36","author":"T Zhan","year":"2017","unstructured":"Zhan, T., Rindtorff, N. & Boutros, M. Wnt signaling in cancer. Oncogene 36, 1461\u20131473 (2017).","journal-title":"Oncogene"},{"key":"70452_CR76","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","volume":"7","author":"JQ Liu","year":"2022","unstructured":"Liu, J. Q. et al. Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduct. Tar. 7, 3 (2022).","journal-title":"Signal Transduct. Tar."},{"key":"70452_CR77","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41419-023-05712-4","volume":"14","author":"H Li","year":"2023","unstructured":"Li, H. et al. PTPN14 promotes gastric cancer progression by PI3KA\/AKT\/mTOR pathway. Cell Death Dis. 14, 188 (2023).","journal-title":"Cell Death Dis."},{"key":"70452_CR78","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.molcel.2009.06.014","volume":"35","author":"LC Chuang","year":"2009","unstructured":"Chuang, L. C. et al. Phosphorylation of Mcm2 by Cdc7 promotes pre-replication complex assembly during cell-cycle Re-entry. Mol. Cell 35, 206\u2013216 (2009).","journal-title":"Mol. Cell"},{"key":"70452_CR79","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0378-1119(00)00511-4","volume":"262","author":"PM Jorgensen","year":"2001","unstructured":"Jorgensen, P. M. et al. Characterisation of the human APC1, the largest subunit of the anaphase-promoting complex. Gene 262, 51\u201359 (2001).","journal-title":"Gene"},{"key":"70452_CR80","doi-asserted-by":"crossref","unstructured":"Castronovo, V. et al. The angiogenesis suppressor gene AKAP12 is under the epigenetic control of HDAC7 in endothelial cells. Angiogenesis 15, 543\u2013554 (2012).","DOI":"10.1007\/s10456-012-9279-8"},{"key":"70452_CR81","doi-asserted-by":"publisher","first-page":"e13325","DOI":"10.1111\/apha.13325","volume":"228","author":"PM Benz","year":"2020","unstructured":"Benz, P. M. et al. AKAP12 deficiency impairs VEGF-induced endothelial cell migration and sprouting. Acta Physiol. 228, e13325 (2020).","journal-title":"Acta Physiol."},{"key":"70452_CR82","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1158\/1078-0432.CCR-18-1942","volume":"25","author":"JJ Luke","year":"2019","unstructured":"Luke, J. J., Bao, R., Sweis, R. F., Spranger, S. & Gajewski, T. F. WNT\/\u03b2-catenin pathway activation correlates with immune exclusion across human cancers. Clin. Cancer Res. 25, 3074\u20133083 (2019).","journal-title":"Clin. Cancer Res."},{"key":"70452_CR83","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-019-0666-1","volume":"7","author":"S Raghavan","year":"2019","unstructured":"Raghavan, S., Mehta, P., Xie, Y., Lei, Y. L. & Mehta, G. Ovarian cancer stem cells and macrophages reciprocally interact through the WNT pathway to promote pro-tumoral and malignant phenotypes in 3D engineered microenvironments. J. Immunother. Cancer 7, 190 (2019).","journal-title":"J. Immunother. Cancer"},{"key":"70452_CR84","doi-asserted-by":"publisher","first-page":"5854","DOI":"10.1038\/s41388-021-01986-0","volume":"40","author":"F Zhang","year":"2021","unstructured":"Zhang, F. et al. \u03b2-Catenin-CCL2 feedback loop mediates crosstalk between cancer cells and macrophages that regulates breast cancer stem cells. Oncogene 40, 5854\u20135865 (2021).","journal-title":"Oncogene"},{"key":"70452_CR85","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s10456-005-5612-9","volume":"8","author":"TNH Masckauch\u00e1n","year":"2005","unstructured":"Masckauch\u00e1n, T. N. H., Shawber, C. J., Funahashi, Y., Li, C.-M. & Kitajewski, J. Wnt\/\u03b2-catenin signaling induces proliferation, survival and interleukin-8 in human endothelial cells. Angiogenesis 8, 43\u201351 (2005).","journal-title":"Angiogenesis"},{"key":"70452_CR86","doi-asserted-by":"publisher","first-page":"5482","DOI":"10.1200\/JCO.22.02777","volume":"41","author":"H Burris 3rd","year":"2023","unstructured":"Burris, H. 3rd et al. Improvements in Survival and Clinical Benefit With Gemcitabine as First-Line Therapy for Patients With Advanced Pancreas Cancer: A Randomized Trial. J. Clin. Oncol. 41, 5482\u20135492 (2023).","journal-title":"J. Clin. Oncol."},{"key":"70452_CR87","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.canlet.2021.08.029","volume":"521","author":"Z Gu","year":"2021","unstructured":"Gu, Z., Du, Y., Zhao, X. & Wang, C. Tumor microenvironment and metabolic remodeling in gemcitabine-based chemoresistance of pancreatic cancer. Cancer Lett. 521, 98\u2013108 (2021).","journal-title":"Cancer Lett."},{"key":"70452_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2020.01.004","volume":"13","author":"A Bulle","year":"2020","unstructured":"Bulle, A. et al. Gemcitabine recruits M2-type tumor-associated macrophages into the stroma of pancreatic cancer. Transl. Oncol. 13, 100743 (2020).","journal-title":"Transl. Oncol."},{"key":"70452_CR89","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/s41419-024-06950-w","volume":"15","author":"J Zhang","year":"2024","unstructured":"Zhang, J. et al. BRCA1 orchestrates the response to BI-2536 and its combination with alisertib in MYC-driven small cell lung cancer. Cell Death Dis. 15, 551 (2024).","journal-title":"Cell Death Dis."},{"key":"70452_CR90","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.biopha.2015.07.005","volume":"74","author":"BP Kumar","year":"2015","unstructured":"Kumar, B. P., Rajput, S., Bharti, R., Parida, S. & Mandal, M. BI2536\u2013A PLK inhibitor augments paclitaxel efficacy in suppressing tamoxifen induced senescence and resistance in breast cancer cells. Biomed. Pharmacother. 74, 124\u2013132 (2015).","journal-title":"Biomed. Pharmacother."},{"key":"70452_CR91","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1093\/hmg\/ddp481","volume":"19","author":"W Chang","year":"2010","unstructured":"Chang, W., Barnes, A. M., Cabral, W. A., Bodurtha, J. N. & Marini, J. C. Prolyl 3-hydroxylase 1 and CRTAP are mutually stabilizing in the endoplasmic reticulum collagen prolyl 3-hydroxylation complex. Hum. Mol. Genet. 19, 223\u2013234 (2010).","journal-title":"Hum. Mol. Genet."},{"key":"70452_CR92","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1073\/pnas.1307597111","volume":"111","author":"E Pokidysheva","year":"2014","unstructured":"Pokidysheva, E. et al. Biological role of prolyl 3-hydroxylation in type IV collagen. Proc. Natl. Acad. Sci. USA 111, 161\u2013166 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"70452_CR93","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3390\/cancers11030406","volume":"11","author":"A Kowalski-Chauvel","year":"2019","unstructured":"Kowalski-Chauvel, A. et al. Alpha6-integrin regulates FGFR1 expression through the ZEB1\/YAP1 transcription complex in glioblastoma stem cells resulting in enhanced proliferation and stemness. Cancers 11, 406 (2019).","journal-title":"Cancers"},{"key":"70452_CR94","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/ncb1767","volume":"10","author":"Z Fu","year":"2008","unstructured":"Fu, Z. et al. Plk1-dependent phosphorylation of FoxM1 regulates a transcriptional programme required for mitotic progression. Nat. Cell Biol. 10, 1076\u20131082 (2008).","journal-title":"Nat. Cell Biol."},{"key":"70452_CR95","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3390\/cancers13030387","volume":"13","author":"D Wang","year":"2021","unstructured":"Wang, D. et al. A regulatory loop of FBXW7-MYC-PLK1 controls tumorigenesis of MYC-driven medulloblastoma. Cancers 13, 387 (2021).","journal-title":"Cancers"},{"key":"70452_CR96","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s42003-021-01653-w","volume":"4","author":"M Dufies","year":"2021","unstructured":"Dufies, M. et al. Plk1, upregulated by HIF-2, mediates metastasis and drug resistance of clear cell renal cell carcinoma. Commun. Biol. 4, 166 (2021).","journal-title":"Commun. Biol."},{"key":"70452_CR97","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1016\/j.cmet.2019.02.001","volume":"29","author":"CJ Halbrook","year":"2019","unstructured":"Halbrook, C. J. et al. Macrophage-Released Pyrimidines Inhibit Gemcitabine Therapy in Pancreatic Cancer. Cell Metab. 29, 1390\u20131399 (2019).","journal-title":"Cell Metab."},{"key":"70452_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-017-0701-0","volume":"16","author":"K Chen","year":"2017","unstructured":"Chen, K. et al. Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancer. Mol. Cancer 16, 1\u201311 (2017).","journal-title":"Mol. Cancer"},{"key":"70452_CR99","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1038\/s41388-019-1135-5","volume":"39","author":"T Qian","year":"2020","unstructured":"Qian, T. et al. PINCH-1 interacts with myoferlin to promote breast cancer progression and metastasis. Oncogene 39, 2069\u20132087 (2020).","journal-title":"Oncogene"},{"key":"70452_CR100","doi-asserted-by":"publisher","DOI":"10.1186\/s12938-016-0161-6","volume":"15","author":"J Shu","year":"2016","unstructured":"Shu, J., Dolman, G., Duan, J., Qiu, G. & Ilyas, M. Statistical colour models: an automated digital image analysis method for quantification of histological biomarkers. Biomed. Eng. Online 15, 46 (2016).","journal-title":"Biomed. Eng. Online"},{"key":"70452_CR101","doi-asserted-by":"publisher","first-page":"3545","DOI":"10.1681\/ASN.2016091021","volume":"28","author":"Y Sun","year":"2017","unstructured":"Sun, Y. et al. Kindlin-2 association with Rho GDP-dissociation inhibitor \u03b1 suppresses Rac1 activation and podocyte injury. J. Am. Soc. Nephrol. 28, 3545\u20133562 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"70452_CR102","doi-asserted-by":"publisher","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","volume":"34","author":"S Chen","year":"2018","unstructured":"Chen, S., Zhou, Y., Chen, Y. & Gu, J. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 34, i884\u2013i890 (2018).","journal-title":"Bioinformatics"},{"key":"70452_CR103","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","volume":"37","author":"D Kim","year":"2019","unstructured":"Kim, D., Paggi, J. M., Park, C., Bennett, C. & Salzberg, S. L. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat. Biotechnol. 37, 907\u2013915 (2019).","journal-title":"Nat. Biotechnol."},{"key":"70452_CR104","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"70452_CR105","doi-asserted-by":"publisher","first-page":"4864","DOI":"10.1021\/acs.analchem.6b00631","volume":"88","author":"W Chen","year":"2016","unstructured":"Chen, W. et al. Simple and integrated spintip-based technology applied for deep proteome profiling. Anal. Chem. 88, 4864\u20134871 (2016).","journal-title":"Anal. Chem."},{"key":"70452_CR106","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/s41589-023-01497-x","volume":"20","author":"Y Weng","year":"2024","unstructured":"Weng, Y. et al. DeKinomics pulse-chases kinase functions in living cells. Nat. Chem. Biol. 20, 615\u2013623 (2024).","journal-title":"Nat. Chem. Biol."},{"key":"70452_CR107","doi-asserted-by":"publisher","first-page":"3693","DOI":"10.1039\/C8AN00792F","volume":"143","author":"W Chen","year":"2018","unstructured":"Chen, W., Chen, L. & Tian, R. An integrated strategy for highly sensitive phosphoproteome analysis from low micrograms of protein samples. Analyst. 143, 3693\u20133701 (2018).","journal-title":"Analyst"},{"key":"70452_CR108","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.chroma.2017.03.026","volume":"1498","author":"Y Yao","year":"2017","unstructured":"Yao, Y. et al. An immobilized titanium (IV) ion affinity chromatography adsorbent for solid phase extraction of phosphopeptides for phosphoproteome analysis. J. Chromatogr. A 1498, 22\u201328 (2017).","journal-title":"J. Chromatogr. A"},{"key":"70452_CR109","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/nbt.1511","volume":"26","author":"J Cox","year":"2008","unstructured":"Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized ppb-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367\u20131372 (2008).","journal-title":"Nat. Biotechnol."},{"key":"70452_CR110","doi-asserted-by":"publisher","first-page":"12574","DOI":"10.1021\/acs.analchem.8b02667","volume":"90","author":"M Ke","year":"2018","unstructured":"Ke, M. et al. Integrated and quantitative proteomic approach for charting temporal and endogenous protein complexes. Anal. Chem. 90, 12574\u201312583 (2018).","journal-title":"Anal. Chem."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70452-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70452-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70452-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T02:05:01Z","timestamp":1777514701000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70452-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":110,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["70452"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-70452-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]},"assertion":[{"value":"15 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3913"}}